The rising prevalence in GLP-1 drugs for diabetes has led to a debate about delivery routes : transdermal systems versus capsules. Typically, GLP-1 treatments were only available in oral form, but the https://lewistbdo753965.dbblog.net/14246221/glp-1-patches-vs-tablets-what-right-for-the-patient